Research & Development
Pathology & AI
Molecular Diagnostics: Page 4
Viome launches at-home oral disease test
Viome uses the test results to provide consumers with customized food and supplement recommendations that support an individual’s oral and overall health, according to the company.
August 7, 2023
Oxford Nanopore forms German rare disease sequencing research collaboration
The two-year pilot study will assess the benefits and feasibility of incorporating nanopore-based genome sequencing in German clinical practice.
August 4, 2023
Revvity launches automated workstation at AACC 2023 annual meeting
The workstation is a next-generation liquid handler that integrates technologies from Revvity’s existing platforms, designed to streamline workflows in next generation sequencing (NGS) and diagnostic research applications.
July 28, 2023
Grail’s blood test achieves ‘moderate’ sensitivity in people with cancer symptoms
The early detection of cancer is associated with better health outcomes, but many cases are advanced by the time of diagnosis because of the lack of viable screening options. However, Grail also sees a potential role for its test in more advanced cases.
July 27, 2023
Illumina inks deal to sell Pillar Biosciences’ cancer assays
Pillar, which has partnerships with Beckman Coulter Life Sciences and Labcorp, designed its NSCLC and CRC panel to run on the Illumina MiSeq Dx instrument. The instrument is a next-generation sequencing (NGS) platform for in vitro diagnostic testing.
July 26, 2023
NIH’s $140M investigation of genetic variation could unlock a ‘new universe of variants’
Through SMaHT, the NIH aims to catalog the breadth of somatic mosaicism in human tissues.
July 25, 2023
Thermo Fisher launches first reproductive health assays on Ion Torrent sequencer
The products, the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, are the first reproductive health assays available for the company’s Ion Torrent Genexus Integrated Sequencer.
July 21, 2023
Molecular pathology bodies recommend expansion of pharmacogenomic test panels
In its latest project, the working group investigated clinical CYP3A4 and CYP3A5 PGx testing, leading the AMP and its collaborators to issue consensus recommendations on the genes.
July 18, 2023
Whole genome sequencing finds genetic disorders missed by targeted test in babies
WGS found a genetic disorder in 49% of the patients, compared to a 27% detection rate for NewbornDx. Overall, a molecular diagnostic variant was found in 51% of participants; 134 of the 297 identified variants were novel.
July 14, 2023
Epigenetic study links DNA methylation to diseases including breast cancer and diabetes
Through the analysis, the researchers identified 69 associations between CpGs and the prevalence of breast cancer, chronic kidney disease, ischemic heart disease, and type 2 diabetes. The majority of the associations had not previously been described.
July 12, 2023
Quest Diagnostics launches consumer-initiated genetic test kit
The test uses next-generation sequencing (NGS) technology to analyze thousands of DNA variants in the genes associated with the conditions within the test’s scope, searching more regions in the individual’s genome than microarray testing.
July 12, 2023
Novacyt to purchase Yourgene for $21.2M
In a statement, the Camberley, U.K.-based Novacyt said that the acquisition of Yourgene will diversify and expand its testing offerings and geographic footprint, a strategy in part prompted by falling demand for Novacyt’s COVID-19 testing services.
July 11, 2023
Page 4 of 187